The self-expanding device is now available in more than 20 countries and received CE mark approval back in 2020. However, it has not yet been approved by the U.S. Food and Drug Administration for use in the United States.

“I am terribly disappointed physicians who see Medicare patients will receive yet another ridiculous pay cut," Rep. Greg Murphy, MD, said Thursday. 

The BCBS decision pertains to gadopiclenol, a gadolinium-based product sold under the brand names Elucirem and Vueway. 

ACR noted that the state already is struggling to recruit and retain physicians, with the policy potentially exacerbating the problem. 

Rostislav Panev is facing fraud and cybercrime charges in Israel, where he has been accused of being a software developer for hacker group LockBit.

The U.S. Department of Justice said policies at CVS Health forbade pharmacists from discussing patients and providers who may be prescribing opiates in violation of the Controlled Substance Act. 

The cardiologist suffered multiple fractures, had to have a blood clot removed from his skull and now has permanent hearing loss in one ear. He was also left with “severe and crippling depression" following the attack. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.